Related Experiment Video
Updated: Oct 5, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer
Rupert Bartsch1, Simon Peter Gampenrieder2, Gabriel Rinnerthaler2
1Department of Medicine I, Division of Oncology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Austrian breast cancer specialists updated treatment guidelines for HER2-targeted therapies. They developed a consensus-based algorithm evaluating clinical benefit-risk profiles for personalized patient treatment strategies.
Area of Science:
- Oncology
- Pharmacology
Background:
- HER2-targeted therapies are crucial in breast cancer treatment.
- Recent data necessitates re-evaluation of their clinical benefit-risk profiles.
Purpose of the Study:
- To establish a comprehensive clinical benefit-risk profile of HER2-targeted therapies.
- To develop an updated, consensus-based treatment algorithm for breast cancer.
Main Methods:
- Austrian breast cancer specialists convened in December 2020.
- Development of a treatment algorithm occurred over several months in 2021.
- Four distinct patient scenarios were evaluated to assess treatment strategies.
Main Results:
- A consensus was reached on the clinical benefit-risk profiles.
- An updated treatment algorithm was developed.
- Personalized treatment strategies were identified for specific patient profiles.
Conclusions:
- The consensus process successfully updated the treatment algorithm for HER2-targeted therapies.
- The developed algorithm supports personalized treatment decisions in breast cancer care.
- This work provides a framework for optimizing HER2-positive breast cancer management.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...